Inquiry Basket
Macropa-NCS can be coupled with antibodies to form tumor-selective carrier molecules, which can be further combined with radionuclides as specific targeting cancer cell carriers, and is a linker-chelating agent in targeted alpha research (TAT). Macropa-NCS is conjugated to trastuzumab as well as to the prostate-specific membrane antigen-targeting compound RPS-070.
| Catalog Number | Size | Price | Quantity | |
|---|---|---|---|---|
| BADC-01666 | -- | $-- | Inquiry |
Macropa-NCS (N-Chlorosuccinimide conjugated with Macropa) is a chemical reagent widely used in the field of bioconjugation and drug delivery systems. This compound is designed to selectively modify biomolecules, such as proteins and peptides, by reacting with nucleophilic groups like amines or thiols. The NCS (N-chlorosuccinimide) group in Macropa-NCS is highly reactive, allowing for efficient conjugation to biomolecules in a controlled manner. This property makes it an ideal tool for the development of targeted drug delivery systems, where the conjugation of therapeutic agents to antibodies or other targeting moieties is necessary for precise localization of drugs to disease sites, such as tumors or inflammatory tissues.
Another important application of Macropa-NCS is in the creation of antibody-drug conjugates (ADCs). In ADC development, Macropa-NCS can be used to conjugate highly potent cytotoxic drugs to monoclonal antibodies, enabling the targeted delivery of the drug directly to cancer cells. The high reactivity of the NCS group ensures efficient attachment of the drug to the antibody while maintaining the stability of the conjugate during circulation. Once the ADC reaches the target cells, it is internalized and the drug is released, exerting its cytotoxic effect specifically in the tumor microenvironment. This targeted approach minimizes systemic toxicity, which is a significant issue in traditional chemotherapy.
Macropa-NCS also plays a crucial role in the development of imaging agents for diagnostic purposes. The ability of Macropa-NCS to conjugate with various biomolecules allows for the attachment of radiolabeled or fluorescent tags to specific proteins, antibodies, or other molecules. This enables the creation of highly specific imaging agents that can target particular tissues or disease markers. For example, when conjugated to antibodies targeting cancer antigens, Macropa-NCS can be used to generate imaging agents for positron emission tomography (PET) or magnetic resonance imaging (MRI), aiding in the detection and monitoring of tumors in vivo.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, non-natural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
